BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 12045262)

  • 21. Cell cycle attenuation by p120E4F is accompanied by increased mitotic dysfunction.
    Rooney RJ
    Cell Growth Differ; 2001 Oct; 12(10):505-16. PubMed ID: 11682462
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human resting B lymphocytes can serve as accessory cells for anti-CD2-induced T cell activation.
    Hirokawa M; Gray JD; Takahashi T; Horwitz DA
    J Immunol; 1992 Sep; 149(6):1859-66. PubMed ID: 1355500
    [TBL] [Abstract][Full Text] [Related]  

  • 23. T-cell stimulation through the T-cell receptor/CD3 complex regulates CD2 lateral mobility by a calcium/calmodulin-dependent mechanism.
    Liu SQ; Golan DE
    Biophys J; 1999 Mar; 76(3):1679-92. PubMed ID: 10049348
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 1F7 (CD26): a marker of thymic maturation involved in the differential regulation of the CD3 and CD2 pathways of human thymocyte activation.
    Dang NH; Torimoto Y; Shimamura K; Tanaka T; Daley JF; Schlossman SF; Morimoto C
    J Immunol; 1991 Nov; 147(9):2825-32. PubMed ID: 1717577
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DNA damage cell checkpoint activities are altered in monocrotaline pyrrole-induced cell cycle arrest in human pulmonary artery endothelial cells.
    Wilson DW; Lamé MW; Dunston SK; Segall HJ
    Toxicol Appl Pharmacol; 2000 Jul; 166(2):69-80. PubMed ID: 10896848
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Down-regulation of cyclin B1 and up-regulation of Wee1 by berberine promotes entry of leukemia cells into the G2/M-phase of the cell cycle.
    Lin CC; Lin SY; Chung JG; Lin JP; Chen GW; Kao ST
    Anticancer Res; 2006; 26(2A):1097-104. PubMed ID: 16619512
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serine 16 of stathmin as a cytosolic target for Ca2+/calmodulin-dependent kinase II after CD2 triggering of human T lymphocytes.
    le Gouvello S; Manceau V; Sobel A
    J Immunol; 1998 Aug; 161(3):1113-22. PubMed ID: 9686569
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Negative regulation of Wee1 expression and Cdc2 phosphorylation during p53-mediated growth arrest and apoptosis.
    Leach SD; Scatena CD; Keefer CJ; Goodman HA; Song SY; Yang L; Pietenpol JA
    Cancer Res; 1998 Aug; 58(15):3231-6. PubMed ID: 9699647
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immune recognition of cyclin B1 as a tumor antigen is a result of its overexpression in human tumors that is caused by non-functional p53.
    Yu M; Zhan Q; Finn OJ
    Mol Immunol; 2002 May; 38(12-13):981-7. PubMed ID: 12009577
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of tyrosine phosphorylation in human T cells via the CD2 pathway. Regulation by the CD45 tyrosine phosphatase.
    Samelson LE; Fletcher MC; Ledbetter JA; June CH
    J Immunol; 1990 Oct; 145(8):2448-54. PubMed ID: 1976695
    [TBL] [Abstract][Full Text] [Related]  

  • 31. T cells of the human intestinal lamina propria are high producers of interleukin-10.
    Braunstein J; Qiao L; Autschbach F; Schürmann G; Meuer S
    Gut; 1997 Aug; 41(2):215-20. PubMed ID: 9301501
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ectopic expression of cyclin E allows non-endomitotic megakaryoblastic K562 cells to establish re-replication cycles.
    García P; Frampton J; Ballester A; Calés C
    Oncogene; 2000 Mar; 19(14):1820-33. PubMed ID: 10777216
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adenosine inhibits activation-induced T cell expression of CD2 and CD28 co-stimulatory molecules: role of interleukin-2 and cyclic AMP signaling pathways.
    Butler JJ; Mader JS; Watson CL; Zhang H; Blay J; Hoskin DW
    J Cell Biochem; 2003 Aug; 89(5):975-91. PubMed ID: 12874832
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Failure of T lymphocytes from elderly humans to enter the cell cycle is associated with low Cdk6 activity and impaired phosphorylation of Rb protein.
    Arbogast A; Boutet S; Phelouzat MA; Plastre O; Quadri R; Proust JJ
    Cell Immunol; 1999 Oct; 197(1):46-54. PubMed ID: 10555995
    [TBL] [Abstract][Full Text] [Related]  

  • 35. p130/p107/p105Rb-dependent transcriptional repression during DNA-damage-induced cell-cycle exit at G2.
    Jackson MW; Agarwal MK; Yang J; Bruss P; Uchiumi T; Agarwal ML; Stark GR; Taylor WR
    J Cell Sci; 2005 May; 118(Pt 9):1821-32. PubMed ID: 15827088
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Pezcoller lecture: cancer cell cycles revisited.
    Sherr CJ
    Cancer Res; 2000 Jul; 60(14):3689-95. PubMed ID: 10919634
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanisms of proteasome inhibitor PS-341-induced G(2)-M-phase arrest and apoptosis in human non-small cell lung cancer cell lines.
    Ling YH; Liebes L; Jiang JD; Holland JF; Elliott PJ; Adams J; Muggia FM; Perez-Soler R
    Clin Cancer Res; 2003 Mar; 9(3):1145-54. PubMed ID: 12631620
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Definition of a lamina propria T cell responsive state. Enhanced cytokine responsiveness of T cells stimulated through the CD2 pathway.
    Targan SR; Deem RL; Liu M; Wang S; Nel A
    J Immunol; 1995 Jan; 154(2):664-75. PubMed ID: 7529282
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidences for protein kinase C. Activation in T lymphocytes by stimulation of either the CD2 or CD3 antigens.
    Friedrich B; Cantrell DA; Gullberg M
    Eur J Immunol; 1989 Jan; 19(1):17-23. PubMed ID: 2563972
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polyamine analogue induction of the p53-p21WAF1/CIP1-Rb pathway and G1 arrest in human melanoma cells.
    Kramer DL; Vujcic S; Diegelman P; Alderfer J; Miller JT; Black JD; Bergeron RJ; Porter CW
    Cancer Res; 1999 Mar; 59(6):1278-86. PubMed ID: 10096560
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.